Fundraising

For Fundraising enquires please contact Anna on 020 7487 3892, email [email protected] or write to us at

120 New Cavendish Street
London
W1W 6XX

Latest

The “Raid Local” Cycle Challenge

On Sunday 28 June, over 1000 supporters of The Cure Parkinson’s Trust (CPT) took to the saddle to take part in the charity’s “Raid Local” cycle challenge, and have - so far - raised an astonishing £250,000 (including gift aid) for CPT’s vital research into a cure for Parkinson’s.
Parkinson's: the Absense of Appendixes & Tonsils

Recent research of large data in Sweden has shown removal of tonsils and appendixes reduces the risk of Parkinson's.
Welcome to the Raid Local 'Jersey of Hope'
Astrocytes to Dopamine Neurons in One Step

A Chinese research group have shown that 'helper cells' in the brain called astrocytes can be converted to nerve cells, which then can go on to produce dopamine - the brain chemical lost in Parkinson's. This is exciting news, but further research is needed.

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.
Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.
New Evidence Suggests Parkinson's Might Not Start in The Brain

A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut...
Science news

Read the latest Parkinson's science and research news here.
Trials - Repurposed Drugs

Our International Linked Clinical Trials initiative (iLCT) identifies potential new treatments to slow, stop or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.
Apply for Funding
The NAC Trial - the facts
Our story
Diabetes Drug Potential Disease-Modifying Therapy

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.
Alpha-synuclein and Parkinson's

Science news

Read the latest Parkinson's science and research news here. Read more

The Cure Collective

The Cure Collective is an opportunity to join like-minded individuals who are committed to help drive forward the quest to find a cure for Parkinson’s... Read more